March 1st marks the start of both Women's History Month and Endometriosis Month. We'd like to start the month off by sharing this informative article on the connection between endometriosis and ovarian cancer. #cancer #endometriosis #womenshealth medicalnewstoday.com/articles/endom…

Ovarian Organoids to Study Reproductive Health: Researchers at the Harvard Wyss Institute are collaborating with a biotechnology company called Gameto to develop human ovarian organoids that will allow the study of reproductive and… dlvr.it/Sk8YZp @medgadget Patsy Bentley Hall

US study shows racial disparities in ovarian cancer care #ovariancancer #womenshealth #healthcare #cancer
clinicaltrialsarena.com/comment/racial… via Clinical Trials Arena

A 24-year-old says she 'ignored' her bloating and stomach pain until it got so bad she went to the ER. Doctors diagnosed her with ovarian cancer. businessinsider.com/24-year-old-st… #womenshealth #ovariancancer #healthcare #cancer

According to studies reported in the Journal of the National Cancer Institute, longer ovulation duration over the course of a person's lifetime was linked to a higher chance of developing epithelial ovarian cancer. healio.com/news/womens-he… #ovariancancer

Check out the new episode of the Project Medtech Podcast!

The conversation features our own Rachel Robinson and #IGNITE Alumni CL Tian, #PhiexTechnologies and Oriana Papin-Zoghbi, AOA.

Learn more here:
business.massmedic.com/newsroom/Detai…

Do you follow us on #LinkedIn ? Stay up-to-date with all AOA Dx news! linkedin.com/feed/update/ur… #womenshealth #ovariancancer #cancer #startup #socialmedia #reproductivehealth

Oriana Papin-Zoghbi Oriana Papin-Zoghbi, CEO & Co-founder of @AOA_DX & Springboard Enterprises Life Sciences Innovation Program Alumna, speaks on her time in the program & the support we provide for women entrepreneurs!

Stay tuned for our 2023 Life Sciences Innovation Program cohort announcement!

Great article by Dom on how women's health startups are poised to crack glass ceiling with biggest share of digital funding yet. Ft. AOA Oriana Papin-Zoghbi #womenshealth #vc #funding #startup #femtech #ovariancancer
techcrunch.com/2023/01/24/des…

Our Springboard alumna AOA is paving the way for women's health by developing the next frontier in early-stage cancer detection.

Read more about how Springboard is paving the way for women entrepreneurs in Forbes: bit.ly/3ZozC5F!

#femalefounders #womenshealthcare

👩‍🔬 Round-up: Clinical Trial updates from #MayHealth , AOA & Hera Biotech!

Read more about the progress these companies are making on their mission to improve diagnostics and care for women with #PCOS , #endometriosis and #ovariancancer ! 👇
femtechinsider.com/clinical-trial…

Such a great way to kickoff #JPM23 with these incredible women in life science + biotech! #womenshealth #biotech #lifescience #JPM2023 #jpm #femalefounders #jpm health

Today we are proud to share that we have enrolled our first patient in our Ovarian Cancer Early Detection Research Clinical Study! #ovariancancer #womenshealth #femtech #healthcare #cancer aoadx.com/aoa-dx-announc…

21-Year-Old Woman Diagnosed with Ovarian Cancer After Years of Doctors Dismissing Her Pain people.com/health/21-year… #ovariancancer #cancer #womenshealth

Remember ladies, when they ask 'From 1-10 how's your pain?' Make sure you say 12. Several studies support the claim that gender bias in medicine routinely leads to denial of pain relief or medial care for female patients. #womenshealth #health #genderbias
washingtonpost.com/wellness/inter…

US #biotech company AOA has announced the initial validation of GD2 and GD3 tumour marker gangliosides as novel diagnostic markers for early detection of ovarian cancer.

femtechworld.co.uk/news/boston-st… #cancer #ovariancancer #cancer warrior #tech #Health #womenshealth #innovation

Congratulations to our YC S21 alumnae Oriana Papin-Zoghbi & Anna Jeter, Co-Founders of AOA, on being named to Inc.’s Female Founders 100 this year!

💥 They've successfully developed the first non-invasive liquid biopsy test for early ovarian cancer detection. inc.com/female-founders

“In our latest research, we were able to correctly identify disease in over 90% of early-stage subjects.”

Portfolio co. AOA announces initial validation of novel tumor gangliosides as promising diagnostic markers for early detection of ovarian cancer: ow.ly/47Jl50LXxYg

A BIG Congratulations to our #Eddies Alumni that made BostInno's '23 Startups to Watch in Boston in 2023!' 🤩

➡️ AOA
➡️ Dexai Robotics
➡️ GenH
➡️ HourWork

#innovation #startups #boston #innovators

bizjournals.com/boston/inno/st…

We are thrilled to read about the innovative #lifesciences & #biotech #startups grabbing the headlines in the Boston Business Journal! Companies like AOA, Eascra Biotech, FOLX HEALTH, Normunity, & Seaspire Skincare will be exciting to watch in #2023! tinyurl.com/2ksx64ym